TNFRSF1B and neoplasm: Additionally, ADR levels in tumor-infiltrating Tregs were markedly higher in mice treated with TNFR2-PLGA-ADR compared with splenic Tregs, liver Tregs, and tumor-infiltrating endothelial cells (Fig. S4E and F).